SCHEMBL3846233

SCHEMBL3846233

CN1CCN(c2ccnc3ccc(-c4cn(C(c5ccccc5)(c5ccccc5)C5C=CC=CC5)nc4C(F)(F)F)cc23)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPKAPK2 P49137 6/20 0.40
ALDH1A1 P00352 5/20 0.38
CYP1A2 P05177 5/20 0.38
CYP3A4 P08684 5/20 0.38
TSHR P16473 4/20 0.38
HIF1A Q16665 4/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
CYP2D6 P10635 3/20 0.38
CYP2C19 P33261 3/20 0.38
USP2 O75604 3/20 0.38
MAPK1 P28482 3/20 0.38
CDK4 P11802 2/20 0.34
CCND3 P30281 2/20 0.34
GSK3B P49841 2/20 0.34
CCNT1 O60563 1/20 0.34
CCNK O75909 1/20 0.34
CDK14 O94921 1/20 0.34
CDK1 P06493 1/20 0.34
CCNB1 P14635 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3847495 0.91 CYP2C19 (0.38) MAPKAPK2ALDH1A1CYP1A2CYP3A4TSHR
SCHEMBL3850600 0.91 NCF1 (0.41) ALDH1A1CYP1A2CYP3A4CYP2C19USP2
SCHEMBL3848853 0.90 ALDH1A1 (0.36) MAPKAPK2ALDH1A1CYP1A2CYP3A4TSHR
SCHEMBL3848729 0.90 CHRM4 (0.34) MAPKAPK2CYP3A4HPGD
SCHEMBL3850114 0.89 MEN1 (0.35) ALDH1A1CYP3A4MEN1KMT2ACDK8
SCHEMBL3845803 0.89 CTSS (0.33) MAPKAPK2ALDH1A1KDM4ESMN1; SMN2
SCHEMBL3847788 0.87 CYP8B1 (0.32) CYP3A4HPGD
SCHEMBL3848225 0.85 PIK3CA (0.33) ALDH1A1MAPK1LMNAKDM4ESMN1; SMN2
SCHEMBL3846942 0.85 SLC22A12 (0.34) CYP3A4HPGD
SCHEMBL3850527 0.85 CYP1A2 (0.36) MAPKAPK2ALDH1A1CYP1A2CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed